A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers
Status:
COMPLETED
Trial end date:
2024-09-29
Target enrollment:
Participant gender:
Summary
This is a randomized (1:1), double-blind, double-dummy, phase I study to compare the effects of Omadacycline versus Moxifloxacin on gut microbiota and the resistomes in healthy adult volunteers.The study consists of 3 phases: Screening, double-blind treatment, and follow-up. Healthy volunteers aged 18-40 years, who meet entry criteria, are randomly assigned to a treatment group using an Interactive Voice Response System/Interactive Web Response System (IxRS) and receive the first dose of the study drug.